Literature DB >> 10833697

The experience of donating bone marrow to a relative.

K A Christopher1.   

Abstract

PURPOSE/
OBJECTIVES: To describe and understand the experience of donating bone marrow to a relative.
DESIGN: Exploratory, descriptive, and qualitative.
SETTING: An urban comprehensive cancer center. SAMPLE: Twelve donors were interviewed--eight women and four men. The average age was 47, and the average length of time since donation was nine months. At the time of the interview, seven recipients were living and five had died.
METHODS: Open-ended, face-to-face, or telephone interviews were conducted within one year of bone marrow donation using an interview guide. MAIN RESEARCH VARIABLES: Psychosocial consequences of donating bone marrow to a relative.
FINDINGS: The main theme was Doing What It Takes When a Family Member Has Cancer. This goal guided the decision-making process, psychological responses, and family relationships once transplantation was necessary. Six subthemes emerged: Dealing With the Donation Procedure, Informational Needs, Psychological Impact of the Donor Role, Managing Family Relationships, Monitoring One's Own Health Before Donation, and Adjusting to the Transplant Recipient's Medical Condition.
CONCLUSIONS: Subjects expressed little or no reluctance to donate bone marrow, and all would repeat the experience. Subjects felt deep personal satisfaction and gratitude for an opportunity to donate. Stressful aspects of the experience related to unanticipated pain after the procedure, negative transplant outcomes, and relationships with the bone marrow recipients' family. IMPLICATIONS FOR NURSING PRACTICE: Predonation assessment should identify donors' need for information as well as types and sources of information, how donors and families have coped with previous crises, and discussions of potential negative transplantation outcomes and impact on donors. Donors' coping and adjustment should be monitored throughout the transplantation process, particularly when coping problems or potential problems are identified or with negative transplantation outcomes. Formal donor support programs should be considered.

Entities:  

Mesh:

Year:  2000        PMID: 10833697

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  8 in total

1.  The influence of the donor-recipient relationship on related donor reactions to stem cell donation.

Authors:  S Labott; A Pfammatter
Journal:  Bone Marrow Transplant       Date:  2014-03-17       Impact factor: 5.483

Review 2.  A review of the haematopoietic stem cell donation experience: is there room for improvement?

Authors:  A Billen; J A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-01-27       Impact factor: 5.483

3.  Experiences and unmet needs of family members requested to donate haematopoietic stem cells to an ill relative: findings from a prospective multi-centre study.

Authors:  Nienke Zomerdijk; Jane Turner; Geoffrey R Hill; David Gottlieb
Journal:  Support Care Cancer       Date:  2020-05-18       Impact factor: 3.603

Review 4.  Hematopoietic stem cell donation.

Authors:  Shu-Huey Chen; Tso-Fu Wang; Kuo-Liang Yang
Journal:  Int J Hematol       Date:  2013-02-19       Impact factor: 2.490

5.  Data mining of mental health issues of non-bone marrow donor siblings.

Authors:  Morihito Takita; Yuji Tanaka; Yuko Kodama; Naoko Murashige; Nobuyo Hatanaka; Yukiko Kishi; Tomoko Matsumura; Yukio Ohsawa; Masahiro Kami
Journal:  J Clin Bioinforma       Date:  2011-07-20

6.  The Core of Sibling Stem Cell Donation - A Grounded Theory Study.

Authors:  Annika M Kisch; Anna Forsberg
Journal:  Open Nurs J       Date:  2017-06-30

7.  Donation of peripheral blood stem cells to unrelated strangers: A thematic analysis.

Authors:  Annelies Billen; J Alejandro Madrigal; Katrina Scior; Bronwen E Shaw; Andre Strydom
Journal:  PLoS One       Date:  2017-10-25       Impact factor: 3.240

8.  Losing the genetic twin: donor grief after unsuccessful unrelated stem cell transplantation.

Authors:  Martina Wanner; Sandra Bochert; Iris M Schreyer; Gabi Rall; Claudia Rutt; Alexander H Schmidt
Journal:  BMC Health Serv Res       Date:  2009-01-07       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.